Literature DB >> 8634711

Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14q24.3.

M Cruts1, H Backhovens, S Y Wang, G Van Gassen, J Theuns, C D De Jonghe, A Wehnert, J De Voecht, G De Winter, P Cras.   

Abstract

Genetic linkage studies have indicated that chromosome 14q24.3 harbours a major locus for early-onset (onset age <65 years) Alzheimer's disease (AD3). Positional cloning efforts have identified a novel gene S182 or presenilin 1 as the AD3 gene. We have mapped S182 in the AD3 candidate region between D14S277 and D14S284 defined by genetic linkage studies in the two chromosome 14 linked, early-onset AD families AD/A and AD/B. We have shown that S182 is expressed in lymphoblasts and have determined the complete cDNA in both brain and lymphoblasts by RT-PCR sequencing. S182 is alternatively spliced in both brain and lymphoblasts within a putative phosphorylation site located 5' in the coding region. We identified two novel mutations, Ile143Thr and Gly384la located in, respectively, the second transmembrane domain and in the sixth hydrophilic loop of the putative transmembrane structure of S182. As families AD/A and AD/B have very similar AD phenotype our observation of two mutations in functionally different domains suggest that onset age and severity of AD may not be very helpful predictors of the location of putative S182 mutations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8634711     DOI: 10.1093/hmg/4.12.2363

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  25 in total

1.  Aberrant amyloid precursor protein (APP) processing in hereditary forms of Alzheimer disease caused by APP familial Alzheimer disease mutations can be rescued by mutations in the APP GxxxG motif.

Authors:  Lisa-Marie Munter; Anne Botev; Luise Richter; Peter W Hildebrand; Veit Althoff; Christoph Weise; Daniela Kaden; Gerd Multhaup
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

Review 2.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

3.  Localization of a gene for autosomal dominant osteopetrosis (Albers-Schönberg disease) to chromosome 1p21.

Authors:  W Van Hul; J Bollerslev; J Gram; E Van Hul; W Wuyts; O Benichou; F Vanhoenacker; P J Willems
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

4.  Aggravated decrease in the activity of nucleus basalis neurons in Alzheimer's disease is apolipoprotein E-type dependent.

Authors:  A Salehi; E J Dubelaar; M Mulder; D F Swaab
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

5.  Dissociation between the processivity and total activity of γ-secretase: implications for the mechanism of Alzheimer's disease-causing presenilin mutations.

Authors:  Omar Quintero-Monzon; Morgan M Martin; Marty A Fernandez; Christina A Cappello; Amanda J Krzysiak; Pamela Osenkowski; Michael S Wolfe
Journal:  Biochemistry       Date:  2011-09-30       Impact factor: 3.162

6.  Presenilin-1-immunoreactive neurons are preserved in late-onset Alzheimer's disease.

Authors:  P Giannakopoulos; C Bouras; E Kövari; J Shioi; N Tezapsidis; P R Hof; N K Robakis
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

7.  The PSEN1 I143T mutation in a Swedish family with Alzheimer's disease: clinical report and quantification of Aβ in different brain regions.

Authors:  Lina Keller; Hedvig Welander; Huei-Hsin Chiang; Lars O Tjernberg; Inger Nennesmo; Asa K Wallin; Caroline Graff
Journal:  Eur J Hum Genet       Date:  2010-07-14       Impact factor: 4.246

8.  High-resolution physical and transcript map of human chromosome 2p21 containing the sitosterolaemia locus.

Authors:  K Lu; M H Lee; J D Carpten; M Sekhon; S B Patel
Journal:  Eur J Hum Genet       Date:  2001-05       Impact factor: 4.246

9.  Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.

Authors:  D Campion; C Dumanchin; D Hannequin; B Dubois; S Belliard; M Puel; C Thomas-Anterion; A Michon; C Martin; F Charbonnier; G Raux; A Camuzat; C Penet; V Mesnage; M Martinez; F Clerget-Darpoux; A Brice; T Frebourg
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

10.  Confronting complexity in late-onset Alzheimer disease: application of two-stage analysis approach addressing heterogeneity and epistasis.

Authors:  Tricia A Thornton-Wells; Jason H Moore; Eden R Martin; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Genet Epidemiol       Date:  2008-04       Impact factor: 2.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.